These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 8844269

  • 1. Distinct conformational preferences of three cyclic beta-casomorphin-5 analogs determined using NMR spectroscopy and theoretical analysis.
    Carpenter KA, Schiller PW, Schmidt R, Wilkes BC.
    Int J Pept Protein Res; 1996 Jul; 48(1):102-11. PubMed ID: 8844269
    [Abstract] [Full Text] [Related]

  • 2. Proton NMR conformational analysis of cyclic beta-casomorphin analogues of the type Tyr-cyclo[N omega-D-Orn-Xaa-Yaa-Gly-].
    Mrestani-Klaus C, Brandt W, Schmidt R, Neubert K, Schiller PW.
    Arch Pharm (Weinheim); 1996 Mar; 329(3):133-42. PubMed ID: 9005812
    [Abstract] [Full Text] [Related]

  • 3. Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects.
    Schmidt R, Vogel D, Mrestani-Klaus C, Brandt W, Neubert K, Chung NN, Lemieux C, Schiller PW.
    J Med Chem; 1994 Apr 15; 37(8):1136-44. PubMed ID: 8164255
    [Abstract] [Full Text] [Related]

  • 4. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
    Schmidt R, Wilkes BC, Chung NN, Lemieux C, Schiller PW.
    Int J Pept Protein Res; 1996 Nov 15; 48(5):411-9. PubMed ID: 8956074
    [Abstract] [Full Text] [Related]

  • 5. The mu- and delta-opioid pharmacophore conformations of cyclic beta-casomorphin analogues indicate docking of the Phe3 residue to different domains of the opioid receptors.
    Brandt W, Stoldt M, Schinke H.
    J Comput Aided Mol Des; 1996 Jun 15; 10(3):201-12. PubMed ID: 8808737
    [Abstract] [Full Text] [Related]

  • 6. Cyclic morphiceptin analogs: cyclization studies and opioid activities in vitro.
    Vogel D, Schmidt R, Hartung K, Demuth HU, Chung NN, Schiller PW.
    Int J Pept Protein Res; 1996 Dec 15; 48(6):495-502. PubMed ID: 8985782
    [Abstract] [Full Text] [Related]

  • 7. Pseudoproline-containing analogues of morphiceptin and endomorphin-2: evidence for a cis Tyr-Pro amide bond in the bioactive conformation.
    Keller M, Boissard C, Patiny L, Chung NN, Lemieux C, Mutter M, Schiller PW.
    J Med Chem; 2001 Nov 08; 44(23):3896-903. PubMed ID: 11689075
    [Abstract] [Full Text] [Related]

  • 8. Reduced peptide bond cyclic somatostatin based opioid octapeptides. Synthesis, conformational properties and pharmacological characterization.
    Kazmierski WM, Ferguson RD, Knapp RJ, Lui GK, Yamamura HI, Hruby VJ.
    Int J Pept Protein Res; 1992 May 08; 39(5):401-14. PubMed ID: 1358847
    [Abstract] [Full Text] [Related]

  • 9. Spectroscopic analysis of [Trp3]-beta-casomorphin analogs. Comparative structure conformation-activity studies.
    Epps DE, Havel HA, Sawyer TK, Staples DJ, Chung NN, Schiller PW, Hartrodt B, Barth A.
    Int J Pept Protein Res; 1991 Apr 08; 37(4):257-67. PubMed ID: 1894441
    [Abstract] [Full Text] [Related]

  • 10. Novel ligands lacking a positive charge for the delta- and mu-opioid receptors.
    Schiller PW, Berezowska I, Nguyen TM, Schmidt R, Lemieux C, Chung NN, Falcone-Hindley ML, Yao W, Liu J, Iwama S, Smith AB, Hirschmann R.
    J Med Chem; 2000 Feb 24; 43(4):551-9. PubMed ID: 10691681
    [Abstract] [Full Text] [Related]

  • 11. Tyr-c[D-Orn-Tyr(Bzl)-Pro-Gly]: a novel antiproliferative acting somatostatin receptor agonist with mu-opioid receptor-sensitizing properties.
    Stirnweiss J, Hartrodt B, Greksch G, Stürzebecher U, Böhmer FD, Neubert K, Liebmann C.
    Br J Pharmacol; 2003 Sep 24; 140(1):13-22. PubMed ID: 12967930
    [Abstract] [Full Text] [Related]

  • 12. 14-membered cyclic opioids related to dermorphin and their partially retro-inverso modified analogues. II. Preferred conformations in solution as studied by 1H-NMR spectroscopy.
    Yamazaki T, Mierke DF, Said-Nejad OE, Felder ER, Goodman M.
    Int J Pept Protein Res; 1992 Feb 24; 39(2):161-81. PubMed ID: 1517015
    [Abstract] [Full Text] [Related]

  • 13. Conformational analysis of the biologically active cyclic analog of beta-casomorphin H-Tyr-cyclo[D-OrnPheProGly].
    Kostetsky PV, Arkhipova SF.
    Biochemistry (Mosc); 1999 Sep 24; 64(9):1005-11. PubMed ID: 10521717
    [Abstract] [Full Text] [Related]

  • 14. Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificity.
    Schiller PW, Weltrowska G, Nguyen TM, Lemieux C, Chung NN, Marsden BJ, Wilkes BC.
    J Med Chem; 1991 Oct 24; 34(10):3125-32. PubMed ID: 1656045
    [Abstract] [Full Text] [Related]

  • 15. Role of hydrophobic substituents in the interaction of opioid Tyr-Tic dipeptide analogs with dodecylphosphocholine micelles. Molecular partitioning in model membrane systems.
    Carpenter KA, Wilkes BC, Weltrowska G, Schiller PW.
    Eur J Biochem; 1996 Nov 01; 241(3):756-64. PubMed ID: 8944763
    [Abstract] [Full Text] [Related]

  • 16. A uniform molecular model of delta opioid agonist and antagonist pharmacophore conformations.
    Brandt W.
    J Comput Aided Mol Des; 1998 Nov 01; 12(6):615-21. PubMed ID: 9879509
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers.
    Schiller PW, Nguyen TM, Lemieux C, Maziak LA.
    J Med Chem; 1985 Dec 01; 28(12):1766-71. PubMed ID: 2999401
    [Abstract] [Full Text] [Related]

  • 18. Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs.
    Zadina JE, Kastin AJ, Ge LJ, Hackler L.
    Life Sci; 1994 Dec 01; 55(24):PL461-6. PubMed ID: 7990646
    [Abstract] [Full Text] [Related]

  • 19. Morphiceptin and beta-casomorphin-5 analogues containing a reduced peptide bond: selective mu-receptor agonists and a novel mu antagonist, H-Tyr-Pro psi (CH2-NH)Phe-Pro-Gly-OH.
    Delaet NG, Verheyden PM, Tourwe D, Van Binst G, Davis P, Burks TF.
    Biopolymers; 1992 Aug 01; 32(8):957-69. PubMed ID: 1330047
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.